Where will the fight to eliminate cancer lead us next?
Founded in 2015, Replimune wasted no time in becoming a leading light in cancer treatment. With its Immulytic™ platform offering a pathway to the elimination of cancer cells and the stimulation of immune system responses to them, Replimune has an inspiring story to tell.
Next week Executive Chairman Philip Astley-Sparke will be sharing the latest chapter in that story at the 2019 Wedbush PacGrow Healthcare Conference in New York. Replimune’s presentation promises to be a highlight of the two day event which takes place at on August 13th and 14th at the Midtown Parker Hotel. Philip Astley-Sparke is scheduled to present at 1.55pm on Tuesday the 13th. We look forward to seeing where Replimune will take us next in their pioneering fight against cancer. All the best for next Tuesday, Philip.
Conversis: helping you speak to the world
To find out more, contact us using the form below.
Please use the form to get in touch
or alternatively give us a call on: +44 (0)1869 255820